Stephen S Lane

Summary

Publications

  1. doi request reprint Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery
    Stephen S Lane
    Associated Eye Care, Stillwater, Minnesota 55082, USA
    J Cataract Refract Surg 39:168-73. 2013
  2. ncbi request reprint Multifocal intraocular lenses
    Stephen S Lane
    Ophthalmology Department, University of Minnesota, MMC 493 Mayo 8493, 420 Delaware, Minneapolis, MN 55455, USA
    Ophthalmol Clin North Am 19:89-105, vi. 2006
  3. ncbi request reprint The Implantable Miniature Telescope for macular degeneration
    Stephen S Lane
    Department of Ophthalmology, University of Minnesota, Stillwater, USA
    Curr Opin Ophthalmol 17:94-8. 2006
  4. doi request reprint Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery
    Stephen S Lane
    Associated Eye Care, 232 Main Street, Stillwater, MN 55082, USA
    J Cataract Refract Surg 34:1451-9. 2008
  5. doi request reprint Comparison of clinical and patient-reported outcomes with bilateral AcrySof toric or spherical control intraocular lenses
    Stephen S Lane
    Associated Eye Care, Stillwater, MN 55082, USA
    J Refract Surg 25:899-901. 2009
  6. doi request reprint Improvements in patient-reported outcomes and visual acuity after bilateral implantation of multifocal intraocular lenses with +3.0 diopter addition: multicenter clinical trial
    Stephen S Lane
    University of Minnesota, Twin Cities, Minneapolis, MN, USA
    J Cataract Refract Surg 36:1887-96. 2010
  7. ncbi request reprint Surgical placement of an optical prosthetic device for end-stage macular degeneration: the implantable miniature telescope
    Kathryn A Colby
    Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 243 Charles St, Ste 808, Boston, MA 02114, USA
    Arch Ophthalmol 125:1118-21. 2007
  8. doi request reprint Correction of high myopia with a phakic intraocular lens: interim analysis of clinical and patient-reported outcomes
    Stephen S Lane
    Associated Eye Care, Stillwater, Minnesota, USA
    J Cataract Refract Surg 37:1426-33. 2011
  9. ncbi request reprint Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery
    Stephen S Lane
    J Cataract Refract Surg 33:53-8. 2007
  10. doi request reprint A new system, the LipiFlow, for the treatment of meibomian gland dysfunction
    Stephen S Lane
    Associated Eye Care, Stillwater, MN, USA
    Cornea 31:396-404. 2012

Detail Information

Publications21

  1. doi request reprint Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery
    Stephen S Lane
    Associated Eye Care, Stillwater, Minnesota 55082, USA
    J Cataract Refract Surg 39:168-73. 2013
    ..To evaluate the efficacy of loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the control of postoperative inflammation in patients having routine cataract surgery...
  2. ncbi request reprint Multifocal intraocular lenses
    Stephen S Lane
    Ophthalmology Department, University of Minnesota, MMC 493 Mayo 8493, 420 Delaware, Minneapolis, MN 55455, USA
    Ophthalmol Clin North Am 19:89-105, vi. 2006
    ..This article reviews clinical and optical data for three unique lens designs: the ReSTOR diffractive intraocular lens (IOL), the Vision Membrane, and the ReZOOM refractive multifocal IOL...
  3. ncbi request reprint The Implantable Miniature Telescope for macular degeneration
    Stephen S Lane
    Department of Ophthalmology, University of Minnesota, Stillwater, USA
    Curr Opin Ophthalmol 17:94-8. 2006
    ..Multispecialty patient management and implications of the study's findings are discussed...
  4. doi request reprint Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery
    Stephen S Lane
    Associated Eye Care, 232 Main Street, Stillwater, MN 55082, USA
    J Cataract Refract Surg 34:1451-9. 2008
    ..To evaluate posterior and anterior segment safety of an intracameral injection of moxifloxacin 0.5% ophthalmic solution as prophylaxis for endophthalmitis in patients having cataract surgery...
  5. doi request reprint Comparison of clinical and patient-reported outcomes with bilateral AcrySof toric or spherical control intraocular lenses
    Stephen S Lane
    Associated Eye Care, Stillwater, MN 55082, USA
    J Refract Surg 25:899-901. 2009
    ..To compare clinical and patient-reported outcomes with bilateral implantation of AcrySof toric or spherical control (Alcon Laboratories Inc) intraocular lenses (IOLs)...
  6. doi request reprint Improvements in patient-reported outcomes and visual acuity after bilateral implantation of multifocal intraocular lenses with +3.0 diopter addition: multicenter clinical trial
    Stephen S Lane
    University of Minnesota, Twin Cities, Minneapolis, MN, USA
    J Cataract Refract Surg 36:1887-96. 2010
    ..To assess changes in patient-reported outcomes, satisfaction, vision quality, and visual acuity after bilateral implantation of multifocal intraocular lenses (IOLs) with a 3.00 D addition (add) in cataract patients...
  7. ncbi request reprint Surgical placement of an optical prosthetic device for end-stage macular degeneration: the implantable miniature telescope
    Kathryn A Colby
    Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 243 Charles St, Ste 808, Boston, MA 02114, USA
    Arch Ophthalmol 125:1118-21. 2007
    ..To describe the surgical procedure for placement of an implantable telescope prosthesis for end-stage age-related macular degeneration...
  8. doi request reprint Correction of high myopia with a phakic intraocular lens: interim analysis of clinical and patient-reported outcomes
    Stephen S Lane
    Associated Eye Care, Stillwater, Minnesota, USA
    J Cataract Refract Surg 37:1426-33. 2011
    ..To assess uncorrected distance visual acuity (UDVA) and patient-reported outcome changes after bilateral anterior chamber angle-fixated phakic intraocular lens (pIOL) implantation for high myopia...
  9. ncbi request reprint Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery
    Stephen S Lane
    J Cataract Refract Surg 33:53-8. 2007
    ..To determine whether nepafenac ophthalmic suspension 0.1% decreases the incidence and severity of inflammation and pain after cataract surgery with posterior chamber intraocular lens implantation...
  10. doi request reprint A new system, the LipiFlow, for the treatment of meibomian gland dysfunction
    Stephen S Lane
    Associated Eye Care, Stillwater, MN, USA
    Cornea 31:396-404. 2012
    ..To evaluate the safety and effectiveness of the LipiFlow System compared to the iHeat Warm Compress (WC) for adults with meibomian gland dysfunction (MGD)...
  11. ncbi request reprint Quantitative assessment of ophthalmic viscosurgical device retention using in vivo confocal microscopy
    W Matthew Petroll
    Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9057, USA
    J Cataract Refract Surg 31:2363-8. 2005
    ..To develop and apply a new laboratory method for in vivo quantitative assessment of the retention of ophthalmic viscosurgical devices (OVDs) following phacoemulsification...
  12. ncbi request reprint Nepafenac: a unique nonsteroidal prodrug
    Stephen S Lane
    University of Minnesota, St Paul, MN 55102, USA
    Int Ophthalmol Clin 46:13-20. 2006
  13. ncbi request reprint CustomCornea wavefront retreatment after conventional laser in situ keratomileusis
    Gary S Schwartz
    Associated Eye Care, Lake Elmo, Minnesota 55042, USA
    J Cataract Refract Surg 31:1502-5. 2005
    ..To evaluate the safety and efficacy of performing laser in situ keratomileusis (LASIK) retreatment using the Alcon CustomCornea system in patients who had prior myopic LASIK using conventional (nonwavefront) software...
  14. doi request reprint Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty
    Edward J Holland
    Cincinnati Eye Institute, Edgewood, KY, USA
    Cornea 27:314-9. 2008
    ..To compare the corneal and aqueous penetration and pharmacokinetics of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions and their effect on corneal reepithelialization after penetrating keratoplasty...
  15. ncbi request reprint Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results
    Henry L Hudson
    Retina Centers, Tucson, Arizona, USA
    Ophthalmology 113:1987-2001. 2006
    ..To evaluate the safety and efficacy of an implantable visual prosthetic device (IMT; VisionCare Ophthalmic Technologies, Saratoga, CA) in patients with bilateral, end-stage age-related macular degeneration (AMD)...
  16. ncbi request reprint Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor
    Harold R Katz
    Wilmer Eye Institute and the Krieger Eye Institute, Baltimore, MD 21215, USA
    Cornea 24:955-8. 2005
    ..To investigate the absorption of moxifloxacin into human aqueous humor after administration of moxifloxacin hydrochloride ophthalmic solution, 0.5% as base...
  17. ncbi request reprint Foldable intraocular lens removal/exchange: can it be prevented?
    Stephen S Lane
    Ophthalmology 111:1965-6. 2004
  18. ncbi request reprint Posterior capsule opacification and YAG capsulotomy
    Stephen S Lane
    Am J Ophthalmol 138:635-6. 2004
  19. ncbi request reprint Interlenticular opacification of piggyback acrylic intraocular lenses
    Terrence S Spencer
    Moran Eye Center, University of Utah, Salt Lake City, Utah 84132, USA
    J Cataract Refract Surg 28:1287-90. 2002
    ..The dense interlenticular opacification did not allow separation of the lenses intraoperatively because of the tight adherence of the 2 IOLs...
  20. ncbi request reprint Optical performance of 3 intraocular lens designs in the presence of decentration
    Griffith E Altmann
    Optics Center, Bausch and Lomb, Rochester, New York 14609, USA
    J Cataract Refract Surg 31:574-85. 2005
    ..To study the theoretical optical performance of 3 intraocular lens (IOL) designs in the presence of IOL decentration...
  21. ncbi request reprint Comparison of the biomechanical behavior of foldable intraocular lenses
    Stephen S Lane
    Alcon Research, Ltd, Fort Worth, TX, USA
    J Cataract Refract Surg 30:2397-402. 2004
    ..To compare a standardized battery of biomechanical laboratory tests to assess the performance of popular foldable intraocular lenses (IOLs)...